Physician
Anesthesiology
Dr. Gordon A. Irving, MD
|
|
Give Review
Gordon Irving is an expert in the field of Anesthesiology. He received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Top MD" and "Super Doctor". Gordon A. Irving is also published. He has 27 publications published. The lastest publication: "Waddell signs: distributional properties and correlates.' Gordon Irving is registered with Medicare and accepts Medicare payments.
Publications
- Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain.
- Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multi...
- Long-term Safety of Gastroretentive Gabapentin in Postherpetic Neuralgia Patients.
- Once-daily gastroretentive gabapentin for the management of postherpetic neuralgia: an update for clinicians.
- Management of chronic noncancer pain in depressed patients.
- NGX-4010, a Capsaicin 8% Dermal Patch, Administered Alone or in Combination With Systemic Neuropathic Pain Medications, Reduces Pain in Patients With Postherpetic Neur...
- Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an ...
- Diabetic peripheral neuropathic pain: clinical and quality-of-life issues.
- Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain.
- Contemporary assessment and management of neuropathic pain.
- The cognitive effects of opioids.
- Effects of tourniquet ischemia on current perception thresholds in healthy volunteers.
- Neurophysiological evaluation of zidovudine in asymptomatic HIV-1 infection: a longitudinal placebo-controlled study.
- Waddell signs: distributional properties and correlates.
- Quantitative assessment of differential sensory blockade after lumbar epidural lidocaine.
- Multimodal analgesia for chronic pain: rationale and future directions.
- Painless electrodiagnostic current perception threshold and pain tolerance threshold values in CRPS subjects and healthy controls: a multicenter study.
- Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind,...
- Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study.
- Rational multidrug therapy in the treatment of neuropathic pain.
- Quantitative sensory testing and mapping: a review of nonautomated quantitative methods for examination of the patient with neuropathic pain.
- The placebo response: relationship to outcomes in trials of postherpetic neuralgia.
- Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities.
- Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinic...
- A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.
- A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
Doctors Specialties
- Anesthesiology
- Pain Medicine Anesthesiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Top MD
- Super Doctor
Education
-
University of Texas Health Science Center -
University of Newcastle Upon Tyne Faculty of Medicine
Hospital
-
Swedish Medical Center-Cherry Hill Campus
Drug Facts
| NPI NUMBER | 1316001399 | |
| NPPES Provider LastName | IRVING | |
| NPPES Provider FirstName | GORDON | |
| NPPES Provider ZIPCode | 981041306 | |
| NPPES Provider State | WA | |
| Specialty Description | Pain Management | |
| Total Claim Count | 646.0 | |
| Distinct Opioid Count | 9.0 | |
| Opioid Claim Count | 351.0 | |
| Percent Opioid Claims | 54.33 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1316001399 |
| Last Name Of The Provider | IRVING |
| First Name Of The Provider | GORDON |
| View All |
Similar Doctors
|
|
Dr. Phyllis K. Brundidge, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin T. Kogut, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel J. Doran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephan R. Thilen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald G. Peterson, MD |
|
|
Dr. Janice J. Wu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shahriar Khezri, MD |
|
|
Dr. Ray P. Liao, MD |
|
|
Dr. Christina J. Lemoine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John C. Holder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deepak Sharma, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen J. Souter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clinton W. Piper, MD |
|
|
Dr. Lance M. Relland, MD |
|
|
Dr. Iehab N. Talukder, MD |
|
|
Dr. Brian D. Tompkins, MD
This Doctor is OpenDoctor Recommended.
|